The European Medicines Agency has recommended marketing approval for Alyftrek for cystic fibrosis and Attrogy for a form of ...

Drag Race star The Vivienne's sister Chanel on why she's campaigning to spotlight how ketamine - widely considered a ‘safe’ ...

Researchers at the University of California, Irvine, have developed a groundbreaking therapy for Alzheimer’s disease by using stem cells to program human immune cells for targeted treatment.

Opioids, antidepressants, and some NSAIDs increase the risk of constipation. Find out which ones do and what helps bowel ...

Reviewed By Anton Porsteinsson, MD, Director of the University of Rochester Alzheimer’s Disease Care, Research and Education ...

Positive results of PARP inhibitor and CAR T-cell treatments highlight advances in research for neuroblastoma.

Data highlights novel PARP1 and ATR inhibitors with progress toward next-generation therapies for hard-to-treat malignancies ...

AviadoBio, a pioneering gene therapy company dedicated to developing and delivering potentially transformative medicines for neurodegenerative disorders, today announced the completion of the second ...

Total operating loss from continuing operations increased from $6.6 million in 2023 to $6.9 million in 2024. Research and ...

The decision is a reminder to developers that the agency will not wave through new drugs in the anti-amyloid class now that ... s Peripheral and Central Nervous System Drugs (PCNS) advisory ...

The longtime Colorado State University professor and researcher, survivor of an American wartime internment camp and holder ...